Clin2
NCT06670495Likely a fitRecruiting

HPV types and anal cancer in China

Anal Cancer

Part of Cancer, Digestive system clinical trials.

This study looks at how different types of HPV are linked to anal cancer in China. By testing your tumor sample, the researchers hope to better understand what causes anal cancer, which could help guide prevention and treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
Any age
Study type
Observational

Who can take part

  • You must have anal cancer.
  • You must not have had radiation or chemotherapy for your anal cancer before your sample is taken.
  • You cannot have HIV.
  • You cannot be taking medicines that suppress your immune system after an organ transplant.
  • You must agree to have a tissue sample collected and tested.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04857528Recruiting
Testing HPV DNA in anal and cervical tumors

This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.

Chicago, Illinois
NCT06522256Recruiting
HPV and anal cancer risk 10 years later

This study looks at HPV (the virus that can cause anal cancer) and checks if certain types of high-risk HPV are linked to abnormal cells or cancer in the anus, 10 years after joining the IPERGAY trial. It helps researchers understand long-term risks.

Lyon
NCT07790601Not yet recruiting
Self-collected anal swabs for HPV detection in people with HIV

This study tests a self-collected anal swab for detecting HPV (the virus that can cause anal cancer) in people living with HIV. It aims to see if this simple swab is as accurate as a doctor-collected sample, and may help prevent anal cancer.

Cudgen, New South Wales
NCT07425054Recruiting· Phase 2
Chemoradiation with or without immunotherapy for anal cancer

This trial tests whether adding an immunotherapy drug (retifanlimab) to standard chemoradiation improves outcomes for people with locally advanced anal cancer. The treatment is adjusted based on HPV DNA levels in your blood.

Cleveland, Ohio
NCT07192055Recruiting
At-home sampling to prevent anal cancer

This study tests whether having people collect their own anal samples at home can help find and treat early signs of anal cancer. It is for men and transgender women who have sex with men and who live in or near Chicago, Houston, or Milwaukee.

Chicago, Illinois
NCT06327568Recruiting
Screening for anal cancer and precancer with a new HPV test

This study tests how well a special HPV test (called BD Onclarity™) can find anal cancer or precancer. It is for people at high risk or with known anal abnormalities, and aims to improve early detection.

Milan

Hear when a new Anal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.